We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPU icon
4426
Mega Matrix
MPU
$13.7M
$8K ﹤0.01%
4,587
-2,723
-37% -$5.15K
MTNB icon
4427
Matinas BioPharma
MTNB
$1.49M
$8K ﹤0.01%
325
-62
-16% -$2.06K
MTR
4428
Mesa Royalty Trust
MTR
$5.31M
$8K ﹤0.01%
354
-166
-32% -$2.81K
MXC icon
4429
Mexco Energy
MXC
$20M
$8K ﹤0.01%
631
+405
+179% +$6K
NCMI icon
4430
National CineMedia
NCMI
$252M
$8K ﹤0.01%
3,629
+3,262
+889% +$14.3K
NCPL icon
4431
Netcapital
NCPL
$2.58M
$8K ﹤0.01%
+79
New +$8.53K
NRIX icon
4432
Nurix Therapeutics
NRIX
$2.76B
$8K ﹤0.01%
699
-9,336
-93% -$113K
ODP
4433
DELISTED
ODP
ODP
$8K ﹤0.01%
183
-6,181
-97% -$264K
OTLK icon
4434
Outlook Therapeutics
OTLK
$166M
$8K ﹤0.01%
381
-1,724
-82% -$37.5K
OVBC icon
4435
Ohio Valley Banc Corp
OVBC
$211M
$8K ﹤0.01%
331
-405
-55% -$10.9K
PAG icon
4436
Penske Automotive Group
PAG
$14.3B
$8K ﹤0.01%
66
-2,389
-97% -$272K
PCB icon
4437
PCB Bancorp
PCB
$400M
$8K ﹤0.01%
464
-3,593
-89% -$66.9K
PFIS icon
4438
Peoples Financial Services
PFIS
$717M
$8K ﹤0.01%
154
-167
-52% -$8.89K
PIII icon
4439
P3 Health Partners
PIII
$38.9M
$8K ﹤0.01%
87
+40
+85% +$8.66K
PKBK icon
4440
Parke Bancorp
PKBK
$409M
$8K ﹤0.01%
400
-542
-58% -$11.5K
PRPO icon
4441
Precipio
PRPO
$40.3M
$8K ﹤0.01%
712
+125
+21% +$1.88K
PYXS icon
4442
Pyxis Oncology
PYXS
$191M
$8K ﹤0.01%
6,178
-9,558
-61% -$14.3K
QTWO icon
4443
Q2 Holdings
QTWO
$4.13B
$8K ﹤0.01%
318
-5,740
-95% -$160K
QUAD icon
4444
Quad
QUAD
$507M
$8K ﹤0.01%
1,999
-1,689
-46% -$5.37K
REBN icon
4445
Reborn Coffee
REBN
$11.2M
$8K ﹤0.01%
1,205
+1,074
+820% +$9.51K
LNAI
4446
Lunai Bioworks
LNAI
$10.2M
$8K ﹤0.01%
96
+40
+71% +$5.37K
RFDI icon
4447
First Trust RiverFront Dynamic Developed International ETF
RFDI
$168M
$8K ﹤0.01%
+155
New +$7.95K
RUSHB icon
4448
Rush Enterprises Class B
RUSHB
$9.18B
$8K ﹤0.01%
210
-492
-70% -$17.4K
SBSW icon
4449
Sibanye-Stillwater
SBSW
$7.42B
$8K ﹤0.01%
+756
New +$7.67K
SDOT icon
4450
Sadot Group
SDOT
$11.5M
$8K ﹤0.01%
4
-6
-60% -$6.26K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.